Abstract
The polymorphism rs1344706 in the ZNF804A gene is one of the best-supported risk variants for schizophrenia. The association between ZNF804A rs1344706 and the disease was demonstrated in many studies but only few of them investigated large samples (above 2000 patients and controls). Data presented show the genotypic distribution of ZNF804A rs1344706 in 1265 patients with schizophrenia and 1051 healthy controls from the Russian population. Statistical analysis confirmed the association between rs1344706 and schizophrenia (p = 0.034). The frequency of the risk genotype AA was significantly higher in the group of patients compared to that in controls. In addition, the article provides the data on the severity of schizophrenia symptoms measured with the Positive and Negative Syndrome scale (PANSS) in 951 patients. The severity of symptoms was significantly higher in the carriers of the risk genotype AA compared to the AC genotype and the CC genotype.
Keywords: ZNF804A, Risk, Schizophrenia, PANSS, Negative symptoms
Specifications table
| Subject area | Genetics |
| More specific subject area | Psychiatric genetics, association study |
| Type of data | Table |
| How data was acquired | Genotyping of DNA samples using PCR System (Applied Biosystems (ThermoFisher) USA), psychometric assessment of symptoms of schizophrenia |
| Data format | Raw, analyzed. |
| Experimental factors | Clinical characteristics of patients diagnosed with schizophrenia. Genomic DNA from whole blood samples |
| Experimental features | Genotyping was performed using a PCR-RFLP assay. Schizophrenia symptoms were assessed with the PANSS |
| Data source location | Mental Health Research Center, Moscow, Russia |
| Data accessibility | The data is available within this article |
| Related research article | Zhu M., Liu T., Zhang J. et al. Association between rs1344706 of ZNF804A and schizophrenia: a meta-analysis Genomics Proteomics Bioinformatics. 12 (2014). Pp. 292–296. https://doi.org/10.1016/j.gpb.2014.10.005 |
Value of the data
|
1. Data
The dataset reports the frequencies of alleles and genotypes of ZNF804A rs1344706 determined in patients with schizophrenia and healthy people from the Russian population (Table 1). Table 2 describes demographic characteristics in carriers of different ZNF804A rs1344706 genotypes. Table 3 contains the data on clinical characteristics (age at disease onset and symptom scores) stratified by ZNF804A rs1344706 genotype. Table 4 shows the clinical characteristics of male and female patients with different ZNF804A rs1344706 genotypes. The distribution of genotypes is different for patients and controls (Chi-square = 6.71, df = 2, p = 0.034). The frequency of the risk genotype AA is higher in the group of patients compared to that in controls (p = 0.01). This finding is consistent with other studies [1], [2]. There are no between-genotype differences in age and sex in both groups. ANOVA reveals the effect of sex on the age at disease onset and scores on PANSS positive, negative, general psychopathology subscales (p < 0.05) but not on the total PANSS score. Male patients have younger age at disease onset, lower positive symptom score and higher scores on negative and general psychopathological subscales. The main effect of the ZNF804A rs1344706 genotype on the scores on PANSS subscales and the total PANSS score is shown (p < 0.05). The severity of symptoms is higher in the carriers of the risk genotype AA compared to the AC genotype and the CC genotype. Results from other studies support this finding [3], [4].
Table 1.
Allele and genotype frequencies of ZNF804A rs1344706 in patients with schizophrenia and healthy controls.
| Alleles and genotypes | Patients (1265) |
Controls (1051) |
|---|---|---|
| frequencies of alleles and genotypes | ||
| Allele А, % | 64 | 60 |
| Allele С, % | 36 | 40 |
| Genotype АА, %, (number of patients) | 40.79 (516) | 36.82 (387) |
| Genotype АС, %, (number of patients) | 46.17 (584) | 46.81 (492) |
| Genotype СС, %, (number of patients) | 13.04 (165) | 16.37 (172) |
Table 2.
Demographic characteristics of the subjects with different ZNF804A rs1344706 genotypes.
| Controls | ||||
| Variables |
AA (n = 387) |
AC (n = 492) |
CC (n = 172) |
Total (n = 1051) |
| Men, n (%) | 206 (36.9) | 256 (46.0) | 95 (17.1) | 557 (53) |
| Age, years, mean (SD) | 29.3 (10.6) | 29.1 (9.6) | 29.1 (10.7) | 29.2 (10.1) |
| Women, n (%) | 181 (36.6) | 236 (47.8) | 77 (15.6) | 494 (47) |
| Age, years mean (SD) |
30.1 (11.2) |
32.2 (11.9) |
35.3 (16.2) |
31.9 (12.5) |
| Patients | ||||
| Variables |
AA (n = 516) |
AC (n = 584) |
CC (n = 165) |
Total (n = 1265) |
| Men, n (%) | 222 (40.4) | 258 (46.9) | 70 (12.7) | 550 (43.5) |
| Age, years mean (SD) | 30.3 (12.1) | 31.5 (11.8) | 28.7 (9.6) | 30.8 (11.7) |
| Women, n (%) | 294 (41.1) | 326 (45.6) | 95 (13.3) | 715 (56.5) |
| Age, years mean (SD) | 38.2 (13.3) | 37.3 (12.2) | 39.6 (12.9) | 38.1 (13.2) |
Table 3.
Clinical characteristics of patients with schizophrenia by ZNF804A rs1344706 genotype.
| ZNF804A rs1344706 genotype | ||||
|---|---|---|---|---|
| Variables, mean (SD) | AA (n = 389) | AC (n = 430) | CC (n = 132) | Total (n = 951) |
| Age at onset, years | 23.8 (9.8) | 24.0 (9.7) | 23.6 (8.7) | 23.8 (9.6) |
| PANSS (positive symptoms), score | 24.1 (8.4) | 24.1 (9.0) | 21.7 (7.8) | 23.7 (8.6) |
| PANSS (negative symptoms), score | 23.1 (7.9) | 21.3 (7.2) | 21.7 (7.1) | 22.1 (7.5) |
| PANSS (general psychopathological symptoms), score | 40.3 (13.1) | 37.9 (12.9) | 37.8 (13.2) | 38.9 (13.1) |
| PANSS (total) score | 87.0 (21.9) | 82.9 (20.5) | 81.3 (22.1) | 84.4 (21.4) |
Table 4.
Clinical characteristics of male and female patients with different ZNF804A rs1344706 genotypes.
| Male patients with schizophrenia | ||||
|---|---|---|---|---|
|
ZNF804A rs1344706 genotype | ||||
| Variables, mean (SD) |
AA (n = 133) |
AC (n = 135) |
CC (n = 46) |
Total (n = 314) |
| Age at onset, years | 21.6 (8.6) | 20.6 (6.1) | 21.5 (5.7) | 21.2 (7.3) |
| PANSS (positive symptoms), score | 22.1 (7.6) | 21.5 (7.3) | 19.1 (7.0) | 21.4 (7.4) |
| PANSS (negative symptoms), score | 24.5 (6.6) | 23.0 (6.5) | 20.6 (5.2) | 23.2 (6.4) |
| PANSS (general psychopathological symptoms), score | 42.8 (10.6) | 39.6 (11.2) | 38.2 (10.7) | 40.6 (11.0) |
| PANSS (total), score | 87.8 (18.4) | 83.1 (19.2) | 78.0 (18.5) | 84.4 (19.0) |
|
| ||||
| Female patients with schizophrenia | ||||
|
ZNF804A rs1344706 genotype | ||||
| Variables, mean (SD) | AA (n = 256) | AC (n = 295) | CC (n = 86) | Total (n = 637) |
| Age at onset, years | 25.9 (10.2) | 26.7 (10.6) | 25.4 (10.1) | 26.3 (10.3) |
| PANSS (positive symptoms), score | 24.5 (8.6) | 25.3 (9.4) | 23.1 (7.9) | 24.8 (8.9) |
| PANSS (negative symptoms), score | 22.5 (8.3) | 20.5 (7.4) | 22.3 (7.9) | 23.2 (6.5) |
| PANSS (general psychopathological symptoms), score | 39.2 (13.6) | 37.1 (13.6) | 37.6 (14.4) | 38.0 (13.9) |
| PANSS (total), score | 86.6 (23.5) | 82.7 (21.0) | 83.1 (23.6) | 84.5 (19.0) |
2. Experimental design, materials and methods
2.1. Sample collection and genomic DNA extraction
Schizophrenia sample was selected from patients admitted to psychiatric units of the Mental Health Research Center. The sample included 1265 people, 550 men, 715 women, mean age 34.8 (13.7) years. Healthy controls without a family history of mental diseases were enrolled from Moscow and Moscow region. The control group included 1051 people, 557 men, 494 women, mean age 30.5 (11.4) years. All participants were ethnically Russian. All of them provided the written informed consent for participation in the study. DNA from whole blood was extracted using the standard phenol-chloroform method.
2.2. DNA genotyping
Genotyping was performed using a PCR-RFLP assay [5]. The following primers were used: forward, 5′-AGTGACCTTGGTGGAAATGG-3′and reverse, 5′-TTTTCCAGGTAGGGGATTGG-3. The amplified products were separated in the 8% polyacrylamide gel, stained and visualized under UV light. Genotype frequencies did not deviate from the Hardy- Weinberg equilibrium in both patients (Chi2 = 0; p < 0.05) and control subjects (Chi2 = 0,55; p < 0.05).
2.3. Phenotyping
The diagnosis of schizophrenia was made according to criteria of The International classification of Diseases 10th revision (ICD-10). Clinical symptoms were measured using the Positive and Negative Syndromes Scale (PANSS) [6], a widespread instrument proven to be valid and suitable for evaluation of positive, negative and general psychopathological items. The PANSS interviews were conducted one week before the patient's discharge from the hospital. Because sex-modulated association of ZNF804A with schizophrenia [7], [8] was reported in earlier studies, we additionally considered clinical characteristics separately in men and women.
2.4. Statistical genetic analyses
Allele and genotype frequencies in cases and controls were compared using 2 chi-square contingency tables. ANCOVA with Bonferroni post-hoc test was used with PANSS score or age at onset as a dependent variable and genotype (AA vs AC vs CC) and sex as between-subject factors with age as a covariate.
Acknowledgments
This work was supported by RFBR grant N 19-07-01119.
Footnotes
Transparency document associated with this article can be found in the online version at https://doi.org/10.1016/j.dib.2019.103985.
Supplementary data to this article can be found online at https://doi.org/10.1016/j.dib.2019.103985.
Transparency document
The following is the transparency document related to this article:
Appendix A. Supplementary data
The following is the Supplementary data to this article:
Multimedia component 2
References
- 1.Zhu M., Liu T., Zhang J., Jia S., Tang W., Luo Y. Association between rs1344706 of ZNF804A and schizophrenia: a meta-analysis. Genom. Proteom. Bioinform. 2014;12:292–296. doi: 10.1016/j.gpb.2014.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sudesh R., Thalamuthu A., John S., Thara R., Mowry B., Munirajan A.K. vol. 199. Schizophrenia Research; 2018. Replication of GWAS Identified miR-137 and its Target Gene Polymorphisms in Schizophrenia of South Indian Population and Meta-Analysis with Psychiatric Genomics Consortium; pp. 189–194. [DOI] [PubMed] [Google Scholar]
- 3.Mössner R., Schuhmacher A., Wagner M., Lennertz L., Steinbrecher A., Quednow B.B., Rujescu D., Rietschel M., Maier W. The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms. Eur. Arch. Psychiatry Clin. Neurosci. 2012;262(3):193–197. doi: 10.1007/s00406-011-0235-1. [DOI] [PubMed] [Google Scholar]
- 4.Wickramasinghe A., Tulloch A.D., Hayes R.D., Chang C.K., Broadbent M., Di Forti M., Murray R.M., Iyegbe C., Stewart R. Associations between the schizophrenia susceptibility gene ZNF804A and clinical outcomes in psychosis. Transl. Psychiatry. 2015;5:e698. doi: 10.1038/tp.2015.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Sazci A., Ozel M.D., Ergul E., Yildiz M.A. A polymerase chain reaction-restriction fragment length polymorphism method for screening ZNF804A gene polymorphism (rs1344706) in patients with schizophrenia: a significant association. Genet. Test. Mol. Biomark. 2012;16(3):157–161. doi: 10.1089/gtmb.2011.0142. [DOI] [PubMed] [Google Scholar]
- 6.Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276. doi: 10.1093/schbul/13.2.261. [DOI] [PubMed] [Google Scholar]
- 7.Zhang F., Chen Q., Ye T., Lipska B.K., Straub R.E., Vakkalanka R., Rujescu D., St Clair D., Hyde T.M., Bigelow L., Kleinman J.E., Weinberger D.R. Evidence of sex-modulated association of ZNF804A with schizophrenia. Biol. Psychiatry. 2011;69:914–917. doi: 10.1016/j.biopsych.2011.01.003. [DOI] [PubMed] [Google Scholar]
- 8.Rao S., Yao Y., Ryan J., Jin C., Xu Y., Huang X., Guo J., Wen Y., Mao C., Meyre D., Zhang F. Genetic association of rs1344706 in ZNF804A with bipolar disorder and schizophrenia susceptibility in Chinese populations. Sci. Rep. 2017;7:41140. doi: 10.1038/srep41140. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Multimedia component 2